O-RAN ALLIANCE Announces Cooperation with ATIS, Activities at MWC Barcelona 2023, 7th Release of Open Software and New OTICs
19.1.2023 01:59:00 EET | Business Wire | Press release
New MoU between O-RAN ALLIANCE and ATIS opens the opportunity for ATIS adopting O-RAN specifications
O-RAN ALLIANCE and ATIS signed a Memorandum of Understanding to further both organizations’ mutual objectives to advance the industry towards more intelligent, open, virtualized and global standards-compliant Radio Access Networks (RAN).
“O-RAN is welcoming the opportunity to work with ATIS,” said Alex Jinsung Choi, Chairman of the O-RAN ALLIANCE and SVP Group Technology at Deutsche Telekom. “We look forward to the opportunity to consider ATIS adopting O-RAN specifications for ATIS Open RAN standards and working together to define the next generation of open and intelligent RAN technology.”
O-RAN ALLIANCE event and demos at MWC Barcelona to bring latest updates from the open RAN ecosystem
O-RAN ALLIANCE plans to hold its next industry event on February 28, 2023 from 15:30-16:30 CET at MWC Barcelona 2023, hosted by Deutsche Telekom at Hall 3 Stand 3M31. The event will include:
- Keynotes by Alex Jinsung Choi, Chairman of the O-RAN ALLIANCE and Stefan Engel-Flechsig, O-RAN ALLIANCE’s COO
- Views on open RAN testing & integration and security by CSPs from Asia, Europe and Americas
- Industry panel discussions on regional development (deployments and trials), security, ecosystem maturity and energy efficiency by key CSPs and vendors from the O-RAN ecosystem
Follow our website for speaker lineup and further updates.
More than 60 O-RAN member companies plan to present demonstrations of their O-RAN based technology and solutions at MWC Barcelona or the O-RAN Virtual Exhibition and welcome visitors to join their booths. O-RAN ALLIANCE plans to issue a map of the demos at the exhibition. Follow us on the O-RAN ALLIANCE LinkedIn channel to learn more, closer to the event.
O-RAN Software Community 7th release “G” expanded to 13 project streams
In December 2022, following on the half year release cycle, the O-RAN Software Community (OSC) published its 7th open software release named "G". For the G release, the OSC expanded to 13 project streams, adding a new AI/ML Framework project.
With each release, OSC’s open software continues to greatly help companies to develop, test and integrate their commercial open and intelligent RAN solutions. Contributions to OSC’s open software come from a diverse community, delivering a broad scope of software according to latest O-RAN ALLIANCE specifications.
"I am so delighted to see the 7th release and the addition of the new AI/ML Framework project stream from our open source community," said Chih-Lin I, Chief Scientist from China Mobile and Co-chair of O-RAN Technical Steering Committee. "With O-RAN ALLIANCE moving into its 5th year, we look forward to evolving towards a new phase. I deeply believe that the power of open source is essential in pushing O-RAN's progress to new heights in the coming years."
“The growth of the O-RAN Software Community has been tremendous. With the O-RAN SC G release, this milestone will help further accelerate O-RAN globally and advance the deployment of flexible networks demanding carrier-grade cloud-native infrastructure as we move towards an intelligent systems world fueled by innovative edge applications,” said Gil Hellmann, vice president, Telecom Solutions Engineering, Wind River. “For the latest O-RAN SC G release, Wind River has continued to provide key contributions to the INF project by working with the community to enable more Open RAN related features in StarlingX and implementing a framework supporting the latest published O2 interface, which is pivotal to cloud infrastructure management and deployment operations. We look forward to continuing our close collaboration.”
New Open Testing and Integration Centres (OTIC) approved in Japan and North America
O-RAN ALLIANCE is pleased to announce Japan OTIC and North American OTIC in NYC Metro Area/East (COSMOS) joining the community of Open Testing and Integration Centres. With this addition there are now 9 approved OTICs across Europe, the Americas and Asia.
“Shared testing and integration are key to delivering commercial O-RAN solutions, so it is great to see more OTICs being approved in North America and around the world,” said Igal Elbaz, Network CTO of AT&T and Board member of O-RAN ALLIANCE. “OTICs are also part of O-RAN PlugFests and the O-RAN Certification and Badging program, promoting more confidence in O-RAN products, components, and solutions within the industry.”
"We are delighted with the start of Japan OTIC, pinned by the opening ceremony last month, and believe the neutral and open testing environment for vendors will help to advance O-RAN solutions," said Naoki Tani, EVP and CTO at NTT DOCOMO and Board member of O-RAN ALLIANCE. "NTT DOCOMO has deployed 5G networks nationwide with O-RAN compliant equipment and intends to further expand the O-RAN ecosystem as co-host of Japan OTIC together with YRP R&D Promotion Committee and Japanese operators.”
For more about O-RAN ALLIANCE testing and integration efforts and the OTICs, please visit our website.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 300 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005984/en/
Contact information
O-RAN ALLIANCE PR Contact
Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 09:00:00 EET | Press release
Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, the largest radiology practice in the U.S, with more than 4,000 radiologists in its network. Cognita CXR1 applies a proprietary
SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 09:00:00 EET | Press release
SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag
Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 09:00:00 EET | Press release
For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network operators over the air in just a few seconds, without sending a technician and with minimal disruption to merchants’ activity. For merchants, the experience is seamless: if a network becomes unstable, the payment terminal can automatically reconnect to another available network, often without the merchant even noticing. This deployment represents one of the first large-scale implementations of the SGP.32 eSIM specifi
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 09:00:00 EET | Press release
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc
Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency 1 , and Core EBITDA 2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 08:00:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new product launches across Galderma’s full portfoli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
